
{
    "credit": [
        {
            "email": "tettelin@som.umaryland.edu",
            "name": "Herv√© Tettelin",
            "typeEntity": "Person",
            "typeRoles": [
            ]
        }
    ],
    "function": [
        {
            "operation": [
                {
                    "term": "Peptide immunogenicity prediction",
                    "uri": "http://edamontology.org/operation_0252"
                },
                {
                    "term": "Epitope mapping",
                    "uri": "http://edamontology.org/operation_0416"
                },
                {
                    "term": "Subcellular localisation prediction",
                    "uri": "http://edamontology.org/operation_2489"
                }
            ]
        }
    ],
    "labels": {
        "language": [
            "Perl"
        ],
        "topic": [
            {
                "term": "Immunoproteins, genes and antigens",
                "uri": "http://edamontology.org/topic_2830"
            },
            {
                "term": "Proteomics",
                "uri": "http://edamontology.org/topic_0121"
            },
            {
                "term": "Machine learning",
                "uri": "http://edamontology.org/topic_3474"
            },
            {
                "term": "Sequence sites, features and motifs",
                "uri": "http://edamontology.org/topic_0160"
            },
            {
                "term": "Protein expression",
                "uri": "http://edamontology.org/topic_0108"
            }
        ]
    },
    "publication": [
        {
            "doi": "10.1186/S12864-019-6195-Y",
            "pmcid": "PMC6916091",
            "pmid": "31842745"
        }
    ],
    "summary": {
        "biotoolsCURIE": "biotools:ReVac",
        "biotoolsID": "ReVac",
        "description": "a reverse vaccinology computational pipeline for prioritization of prokaryotic protein vaccine candidates.\n\nBACKGROUND:Reverse vaccinology accelerates the discovery of potential vaccine candidates (PVCs) prior to experimental validation. Current programs typically use one bacterial proteome to identify PVCs through a filtering architecture using feature prediction programs or a machine learning approach. Filtering approaches may eliminate potential antigens based on limitations in the accuracy of prediction tools used. Machine learning approaches are heavily dependent on the selection of training datasets with experimentally validated antigens (positive control) and non-protective-antigens (negative control). The use of one or few bacterial proteomes does not assess PVC conservation among strains, an important feature of vaccine antigens",
        "homepage": "https://github.com/admelloGithub/ReVac-package",
        "name": "ReVac"
    }
}